A Phase II Study of GC101 in NSCLC

NCT07560111 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

BIOLOGICAL: Autologous Tumor Infiltrating Lymphocytes

Sponsor

Shanghai Juncell Therapeutics